Announce Date | 06/12/2025 |
EPS Normalized Actual | $-0.73 (Beat by $0.08) |
EPS GAAP Actual | $-0.73 (Beat by $0.08) |
Revenue Actual | $0.138373B |
Revenue Surprise | Beat by $138.373M |
Announce Date | 08/02/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.26333 |
EPS GAAP Estimate | $-0.26333 |
Revenue Estimate | $0.161673667B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2030 | 2.28 | 8.18 | 2.19612 | 2.39804 | 1 |
Feb 2029 | 2.28 | 8.18 | 2.18171 | 2.39242 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | -0.73 | -0.73 | 0.138373B | 4.14% | 138.37M |
FQ1 2025 (Feb 2025) | 2.31 | 2.31 | 0.24149B | -3.73% | 241.49M |
FQ4 2024 (Nov 2024) | -0.32 | -0.32 | 0.149905B | -2.76% | 149.91M |
FQ3 2024 (Aug 2024) | -0.38 | -0.38 | 0.15659B | 1.32% | 156.59M |
FQ2 2016 (Apr 2016) | -0.58 | -0.58 | 0.0152618B | 100% | 15.26M |
FQ3 2016 (Jul 2016) | -0.58 | -0.58 | 0.0152618B | 100% | 15.26M |
FQ4 2016 (Oct 2016) | -0.0475 | -0.0475 | 0.0229099B | 100% | 22.91M |
FQ1 2017 (Jan 2017) | -0.0475 | -0.0475 | 0.0229099B | 100% | 22.91M |
FQ4 Announce Date
08/02/2025 (Pre-Market)
Consensus EPS Estimates
-0.26333
Consensus Revenue Estimates
0.161673667B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 2.71 | -- | 2.71 | 2.71 | 1 |
FQ4 2026 (Nov 2026) | -0.35 | -- | -0.35695 | -0.34601 | 1 |
FQ3 2026 (Aug 2026) | -0.49 | -- | -0.49973 | -0.48441 | 1 |
FQ2 2026 (May 2026) | -0.92 | 20.65 | -0.93827 | -0.9095 | 1 |
FQ1 2026 (Feb 2026) | 2.228 | -3.68 | 2.1952 | 2.24092 | 1 |
FQ4 2025 (Nov 2025) | -0.19833 | -61.35 | -0.20227 | -0.19607 | 1 |
FQ3 2025 (Aug 2025) | -0.26333 | -44.31 | -0.26856 | -0.26033 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 0.31B | -- | 0.31B | 0.31B | 2 |
FQ4 2026 (Nov 2026) | 0.17B | -- | 0.17B | 0.18B | 2 |
FQ3 2026 (Aug 2026) | 0.18B | -- | 0.18B | 0.19B | 2 |
FQ2 2026 (May 2026) | 0.15B | 9.68 | 0.15B | 0.16B | 2 |
FQ1 2026 (Feb 2026) | 0.25B | 2.74 | 0.25B | 0.25B | 1 |
FQ4 2025 (Nov 2025) | 0.16B | 4.47 | 0.16B | 0.16B | 1 |
FQ3 2025 (Aug 2025) | 0.16B | 3.14 | 0.16B | 0.16B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | -0.73 | -0.73 | 100% | |
FQ1 2025 (Feb 2025) | 2.31 | 2.31 | 100% | |
FQ4 2024 (Nov 2024) | -0.32 | -0.32 | 100% | |
FQ3 2024 (Aug 2024) | -0.38 | -0.38 | 100% | |
FQ2 2016 (Apr 2016) | -0.58 | -0.58 | 100% | |
FQ3 2016 (Jul 2016) | -0.58 | -0.58 | 100% | |
FQ4 2016 (Oct 2016) | -0.0475 | -0.0475 | 100% | |
FQ1 2017 (Jan 2017) | -0.0475 | -0.0475 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $0.14B | $138.37M | 100% |
FQ1 2025 (Feb 2025) | $0B | $0.24B | $241.49M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0.15B | $149.91M | 100% |
FQ3 2024 (Aug 2024) | $0B | $0.16B | $156.59M | 100% |
FQ2 2016 (Apr 2016) | $0B | $0.02B | $15.26M | 100% |
FQ3 2016 (Jul 2016) | $0B | $0.02B | $15.26M | 100% |
FQ4 2016 (Oct 2016) | $0B | $0.02B | $22.91M | 100% |
FQ1 2017 (Jan 2017) | $0B | $0.02B | $22.91M | 100% |